Nuclear for Climate at COP27

Nuclear for Climate at COP27 The Nuclear for Climate delegation successfully participated in the COP27 in Sharm el-Sheikh, achieving great results in terms of engagement, meetings, and events! With 98 badges (plus supporters), the N4C delegation made amazing efforts all these weeks, advocating, answering questions, engaging with people about nuclear, and raising awareness that #NetZeroNeedsNuclear! We have…

Loviisa

Westinghouse And Fortum Signed Partnership For VVER-440 Nuclear Fuel

Westinghouse And Fortum Signed Partnership For VVER-440 Nuclear Fuel Westinghouse Electric Company (ENS Corporate Member) and Fortum recently signed a long-term partnership to develop, license and deliver VVER-440 fuel to the Loviisa Nuclear Power Plant in Finland to guarantee a dependable Western alternative to Russian-supplied fuel. The new and parallel fuel supplier will diversify our…

SMR-160

SMR-160 Project Advances In Czech Republic

SMR-160 Project Advances In Czech Republic US Small Modular Reactor (SMR) developer Holtec announced the signature of a Memorandum of Agreement (MoA) with engineering multinationals Škoda Praha and Hyundai Engineering and Construction to advance the planning for construction of SMR-160s in the Czech Republic. Under the Agreement, the parties will develop the division of responsibilities…

Slovakia

Mochovce-3 Reaches First Criticality

Mochovce-3 Reaches First Criticality Mochovce-3 reactor reached minimum controlled output on 22 October, marking first criticality for the Russia-supplied 440 MW unit. Utility Slovenske Elektrarne, which owns and operates Slovakia’s four commercial reactors, said Mochovce-3 should reach full capacity and begin commercial operation at the beginning of next year. The company said that although a…

Proton Therapy

Commercial Production Of Lutetium-177 Starts At Bruce NPP

Commercial Production Of Lutetium-177 Starts At Bruce NPP The international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM) announced today the start of commercial production of lutetium-177. It marks the first-of-its-kind achievement of a commercial power reactor with additional capability to commercially produce short-lived medical isotopes.…